Evidence map›Paper›PMID 32320395›Full record

ArticlePLoS genetics2020

Inositol 1,4,5-trisphosphate receptors are essential for fetal-maternal connection and embryo viability.

Feili Yang, Lei Huang, Alexandria Tso, Hong Wang, Li Cui, Lizhu Lin, Xiaohong Wang, Mingming Ren, Xi Fang, Jie Liu and 3 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
4.9field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Deletion ofJournal of developmental biology · 2025
    Article
  5. Feto-placental blood vessel development.Development (Cambridge, England) · 2025
    Review
  6. Conditional deletion of IPJournal of gastroenterology · 2025
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Inositol 1,4,5-trisphosphate receptors in cardiomyocyte physiology and disease.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2022
    Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Minimal contribution of IPActa pharmacologica Sinica · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 2 countries.

Feili YangSchool of Chemical Biology and Biotechnology, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, China.
Lei HuangDepartment of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen, China.ORCID 0000-0003-2110-2949
Alexandria TsoUniversity of California San Diego, School of Medicine, Department of Medicine, La Jolla, CA, United States of America.ORCID 0000-0001-5949-7718
Hong WangSchool of Chemical Biology and Biotechnology, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, China.
Li CuiUniversity of California San Diego, School of Medicine, Department of Medicine, La Jolla, CA, United States of America.
Lizhu LinUniversity of California San Diego, School of Medicine, Department of Medicine, La Jolla, CA, United States of America.
Xiaohong WangDepartment of Pharmacology, Tianjin Key Laboratory of Inflammation Biology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.ORCID 0000-0001-8628-243X
Mingming RenDepartment of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen, China.
Xi FangUniversity of California San Diego, School of Medicine, Department of Medicine, La Jolla, CA, United States of America.
Jie LiuDepartment of Pathophysiology, School of Medicine, Shenzhen University, Shenzhen, China.
Zhen HanDepartment of Cardiovascular Surgery, Peking University Shenzhen Hospital, Shenzhen, China.ORCID 0000-0002-0367-2852
Ju ChenUniversity of California San Diego, School of Medicine, Department of Medicine, La Jolla, CA, United States of America.
Kunfu OuyangSchool of Chemical Biology and Biotechnology, State Key Laboratory of Chemical Oncogenomics, Peking University Shenzhen Graduate School, Shenzhen, China.ORCID 0000-0003-0292-375X
University of California San Diego · USPeking University · CNPeking University Shenzhen Hospital · CNShenzhen University · CNTianjin Medical University · CN

Funding

Mediator complex in cardiac development and functionK99HL143210 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI FANG, XI · 2018 to 2019
$314k
NHLBI NIH HHS K99 HL143210
6 · The paper itself

Abstract

Inositol 1,4,5-trisphosphate receptors (IP3Rs) are a family of intracellular Ca2+ release channels located on the ER membrane, which in mammals consist of 3 different subtypes (IP3R1, IP3R2, and IP3R3) encoded by 3 genes, Itpr1, Itpr2, and Itpr3, respectively. Studies utilizing genetic knockout mouse models have demonstrated that IP3Rs are essential for embryonic survival in a redundant manner. Deletion of both IP3R1 and IP3R2 has been shown to cause cardiovascular defects and embryonic lethality. However, it remains unknown which cell types account for the cardiovascular defects in IP3R1 and IP3R2 double knockout (DKO) mice. In this study, we generated conditional IP3R1 and IP3R2 knockout mouse models with both genes deleted in specific cardiovascular cell lineages. Our results revealed that deletion of IP3R1 and IP3R2 in cardiomyocytes by TnT-Cre, in endothelial / hematopoietic cells by Tie2-Cre and Flk1-Cre, or in early precursors of the cardiovascular lineages by Mesp1-Cre, resulted in no phenotypes. This demonstrated that deletion of both IP3R genes in cardiovascular cell lineages cannot account for the cardiovascular defects and embryonic lethality observed in DKO mice. We then revisited and performed more detailed phenotypic analysis in DKO embryos, and found that DKO embryos developed cardiovascular defects including reduced size of aortas, enlarged cardiac chambers, as well as growth retardation at embryonic day (E) 9.5, but in varied degrees of severity. Interestingly, we also observed allantoic-placental defects including reduced sizes of umbilical vessels and reduced depth of placental labyrinth in DKO embryos, which could occur independently from other phenotypes in DKO embryos even without obvious growth retardation. Furthermore, deletion of both IP3R1 and IP3R2 by the epiblast-specific Meox2-Cre, which targets all the fetal tissues and extraembryonic mesoderm but not extraembryonic trophoblast cells, also resulted in embryonic lethality and similar allantoic-placental defects. Taken together, our results demonstrated that IP3R1 and IP3R2 play an essential and redundant role in maintaining the integrity of fetal-maternal connection and embryonic viability.

Indexed as

AnimalsEndothelial Progenitor CellsFemaleFetal Growth RetardationFetal HeartGene DeletionHeart Defects, CongenitalInositol 1,4,5-Trisphosphate ReceptorsMaleMiceMice, Inbred C57BLMyocytes, CardiacPlacentaPregnancyInositol 1,4,5-Trisphosphate Receptors

Identifiers

PMID32320395
PMCPMC7176088
OpenAlexW3017077727

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.